HRSA
HRSA's Office of Pharmacy Affairs, the unit that oversees the 340B program, will get $12.2 million this fiscal year—$1 million more than last year.

Office of Pharmacy Affairs Get Slight Funding Bump

President Biden on Dec. 29 signed a $1.7 trillion omnibus appropriations bill for fiscal year 2023 that gave the 340B drug pricing program a slight funding boost.

The U.S. Health Resources and Services Administration’s Office of Pharmacy Affairs will get $12.2 million this fiscal year, $1 million more than in fiscal 2022, according to a spending table in a congressional explanatory report that went with the bill. The Biden administration sought $17.2 million for OPA.

President Biden on Dec. 29 signed a $1.7 trillion omnibus appropriations bill for fiscal year 2023 that gave the 340B drug pricing program a slight funding boost.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Attend Our Upcoming Webinar

×


Learn More

Sign up for our free news summaries and alerts